180 related articles for article (PubMed ID: 20007135)
1. Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Chabrol A; Cuzin L; Huguet F; Alvarez M; Verdeil X; Linas MD; Cassaing S; Giron J; Tetu L; Attal M; Récher C
Haematologica; 2010 Jun; 95(6):996-1003. PubMed ID: 20007135
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Karthaus M
Eur J Med Res; 2011 Apr; 16(4):145-52. PubMed ID: 21486728
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
[TBL] [Abstract][Full Text] [Related]
4. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Pagano L; Caira M; Candoni A; Offidani M; Martino B; Specchia G; Pastore D; Stanzani M; Cattaneo C; Fanci R; Caramatti C; Rossini F; Luppi M; Potenza L; Ferrara F; Mitra ME; Fadda RM; Invernizzi R; Aloisi T; Picardi M; Bonini A; Vacca A; Chierichini A; Melillo L; de Waure C; Fianchi L; Riva M; Leone G; Aversa F; Nosari A
Haematologica; 2010 Apr; 95(4):644-50. PubMed ID: 19850903
[TBL] [Abstract][Full Text] [Related]
5. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
7. Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
Kim A; Nicolau DP; Kuti JL
Mycoses; 2011 Sep; 54(5):e301-12. PubMed ID: 20557463
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium.
Selleslag D; Vogelaers D; Marbaix S
Acta Clin Belg; 2009; 64(5):393-8. PubMed ID: 19999386
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
[TBL] [Abstract][Full Text] [Related]
11. Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Zwitserloot AM; Warris A; van't Hek LG; van Die LE; Verweij PE; Mavinkurve-Groothuis AM
Pediatr Blood Cancer; 2008 Sep; 51(3):423-6. PubMed ID: 18478572
[TBL] [Abstract][Full Text] [Related]
12. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Björkholm M; Kalin M; Grane P; Celsing F
Infection; 2012 Feb; 40(1):81-5. PubMed ID: 21779887
[TBL] [Abstract][Full Text] [Related]
14. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; Socié G; Porcher R; Ribaud P; Touratier S; Molina JM
Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276
[TBL] [Abstract][Full Text] [Related]
15. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
[TBL] [Abstract][Full Text] [Related]
17. Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.
Fisher BT; Zaoutis T; Dvorak CC; Nieder M; Zerr D; Wingard JR; Callahan C; Villaluna D; Chen L; Dang H; Esbenshade AJ; Alexander S; Wiley JM; Sung L
JAMA; 2019 Nov; 322(17):1673-1681. PubMed ID: 31688884
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
[No Abstract] [Full Text] [Related]
19. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
20. [Three cases of fungemia caused by Blastoschizomyces capitatus].
Koç AN; Copur Çiçek A; Kaynar L; Sav H; Kasap Tekinşen FF; Atalay MA
Mikrobiyol Bul; 2013 Oct; 47(4):734-41. PubMed ID: 24237444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]